Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Sir Auric Goldfinger who wrote (1171)	2/2/1999 11:32:00 PM
From: Sergio H	Respond to of 1476

Little Shorty, I agree. It's an excellent report...giving factual evidence that this stock may be a future gold mine and laying down the drawbacks for someone looking to make a quick buck. Amigo Sergio

To: Sir Auric Goldfinger who wrote (1171)	2/2/1999 11:37:00 PM
From: John R Resseger	Read Replies (2) \| Respond to of 1476

Auric What is your problem. When Paine Webber or Hornblower and Weeks issues a report on Intel or Merck do they not have an inventory? I don't understand your attitude. If you believe that a company is legitimate and has good prospects, why not spread the news? You short stocks and then do everything in your power to make the stock go down. Do you say ...boys and girls I'm going to cover I'll give you all 2 days to cover first? I don't think so. This stock has a market cap of $20M Glaxo had only one product, Zantex that only treated the symptoms of ulcers and had a Market cap of $9Billion!!! Just one of ANTX's four vaccines in human trials cures what $9Billion Zantex treated the just symptons. So go take a FF! Indians in 7